Welcome to Issue 6!
Having a chronic illness can easily dominate your life. It affects your finances, your relationships, and how much energy you need just to get basic services out of your healthcare. I can’t count how many people I’ve spoken to (and I am one of these) who at some point threw their hands in the air when trying to navigate some arbitrary maze just to get the treatments or testing their doctor wanted them to get. There are so many barriers. But when you have a rare disease, multiply all those challenges by thousand.
Samantha, one of our patient contributors, has experienced this super-challenge. Whether its arguing with insurance, or the pharmacy, or the doctors at the hospital there seem to be nothing but obstacles between what she needs and what she gets, thus her quote, “Going to the hospital almost always means getting worse before they make me better”.
One such obstacle for other rare and chronic illnesses are independent agencies like ICER who, under no legal authority, insert themselves into the discussion of whether or not a given treatment is financially justifiable. In that process, people living with rare diseases are especially disadvantaged because metrics like the Quality Adjusted Life Year that is used to evaluate financial feasibility measures each of them as less than one healthy life.
This is why Patients Rising will be at the MIT Samberg Conference Center in Cambridge Massachusetts on July 25th, to make sure the Institute for Clinical and Economic Review hear the Duchenne Muscular Dystrophy community and other rare and chronic disease families loud and clear when they ask who put ICER in charge of their healthcare and proclaim that they are #notworthless than 1 healthy patient.
-- Terry
|